The largest database of trusted experimental protocols

6 protocols using suramin

1

Purinergic receptor blockade in LPS-induced lung injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mice received an i.t. administration of either vehicle (1xPBS), 100 µM Suramin (Cayman Chemical, USA), 100 µM PPADS (4-[[4-formyl-5hydroxy-6-methyl-3-[(phosphonooxy)methyl]-2-pyrinidyl]azo]-1,3-benzenedisulfonic acid tetrasodium salt) (Tocris Bioscience, UK) or 4 U/mL apyrase (Sigma Aldrich, Germany) in 80 µL total volume one hour prior (prophylactic) or 24 hours after (therapeutic) LPS instillation. The concentrations were chosen based on established literature (9 (link)) and preliminary dose-response studies aiming to achieve effective receptor blockade within our experimental system. Mice were sacrificed 24 hours after both LPS application in the prophylactic and antagonist treatment in the therapeutic setting.
+ Open protocol
+ Expand
2

Cardiac and Endothelial Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
iCell® cardiomyocytes (Cat. No. CMC-100-010-001) and respective plating and maintenance media, iCell® endothelial cells (Cat. No. ECC-100-010-001) and their requisite media supplements were purchased from FujiFilm Cellular Dynamics International. Trypan blue solution (0.4%) and penicillin/streptomycin ( 50mg/ml ) were obtained from Life Technologies. Dimethyl sulfoxide (DMSO, tissue culture grade) was purchased from Santa Cruz Biotechnology. Chloroquine phosphate, nocodazole, suramin, and tetraoctyl ammonium bromide (TAB) were from Cayman Chemical. Isoproterenol and propranolol were purchased from Molecular Devices, and cisapride was obtained from Sigma Aldrich. VascuLife® containing Vascular Endothelial Growth Factor (VEGF) Medium Complete Kits recommended for iCell®-endothelial cells culture were purchased from Lifeline Cell Technology. Pooled HUVECs in EGM-2 media (Cat. No. CC2519A) and EGM™-2 BulletKits™ were obtained from Lonza. Biological reagents and cellular dyes, including Calcein AM, fibronectin, Geltrex™ LDEV-Free reduced growth factor basement membrane, Hoechst 33342, and TrypLE™ Express were procured from Life Technologies. Media, supplements, and positive controls, including fetal bovine serum, histamine, FluoroBright Dulbecco’s Modified Eagle’s Medium (DMEM), and Medium 199 were purchased from Fisher Scientific.
+ Open protocol
+ Expand
3

Cellular Stress Signaling Pathway Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin (sc-8017), LAMP1 (sc-20011), phospho-PERK (sc-32577), PERK (sc-13073), phospho-c-Jun (sc-822), c-Jun (sc-376488), SERCA2 (sc-376235, sc-8095), ATF6 (sc-22799), eIF2α (sc-11386), CaMKII (sc-5306), α1C/Cav1.2 (sc-16229-R), α1D/Cav1.3 (sc-25687), LC3 (sc-271625) and p62 (sc-28359) antibodies were obtained from Santa Cruz Biotechnology, Inc. IRE1α (3294), phospho-CaMKII (12716), phospho-eIF2α (3398), PERK (5683), LC3 (2775), p62 (5114) and Calnexin (2679) antibodies were purchased from Cell Signaling Technology, Inc. Pan-keratin antibody was obtained from Dr. Omary (University of Michigan)65 (link). Actin (JLA20) and tubulin (T5168) antibodies were purchased from Developmental Studies Hybridoma Bank (DSHB) and Sigma, respectively. Fatty acid free and low endotoxin bovine serum albumin (BSA), palmitic acid (PA), stearic acid (SA), oleic acid (OA), docosahexaenoic acid (DHA), tunicamycin (Tm), thapsigargin (Tg), butylated hydroxyanisole (BHA), N-acetylcysteine (NAC), chlorocresol, L-cycloserine, glucagon, phenylephrine, vasopressin, verapamil and nicardipine were purchased from Sigma. SP600125, bafilomycin and rapamycin were from LC Labs, and fumonisin B1 and suramin were from Cayman Chemical.
+ Open protocol
+ Expand
4

Cellular Stress Signaling Pathway Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin (sc-8017), LAMP1 (sc-20011), phospho-PERK (sc-32577), PERK (sc-13073), phospho-c-Jun (sc-822), c-Jun (sc-376488), SERCA2 (sc-376235, sc-8095), ATF6 (sc-22799), eIF2α (sc-11386), CaMKII (sc-5306), α1C/Cav1.2 (sc-16229-R), α1D/Cav1.3 (sc-25687), LC3 (sc-271625) and p62 (sc-28359) antibodies were obtained from Santa Cruz Biotechnology, Inc. IRE1α (3294), phospho-CaMKII (12716), phospho-eIF2α (3398), PERK (5683), LC3 (2775), p62 (5114) and Calnexin (2679) antibodies were purchased from Cell Signaling Technology, Inc. Pan-keratin antibody was obtained from Dr. Omary (University of Michigan)65 (link). Actin (JLA20) and tubulin (T5168) antibodies were purchased from Developmental Studies Hybridoma Bank (DSHB) and Sigma, respectively. Fatty acid free and low endotoxin bovine serum albumin (BSA), palmitic acid (PA), stearic acid (SA), oleic acid (OA), docosahexaenoic acid (DHA), tunicamycin (Tm), thapsigargin (Tg), butylated hydroxyanisole (BHA), N-acetylcysteine (NAC), chlorocresol, L-cycloserine, glucagon, phenylephrine, vasopressin, verapamil and nicardipine were purchased from Sigma. SP600125, bafilomycin and rapamycin were from LC Labs, and fumonisin B1 and suramin were from Cayman Chemical.
+ Open protocol
+ Expand
5

Footpad Inflammation Measurement in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue inflammation studies were performed using NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice (The Jackson Laboratory). Footpads were measured prior to injection using a dial thickness caliper gauge (Swiss Precision Instruments). iNKT cells and DCs (1–3 × 105 of each) were mixed at a 1:1 ratio and pelleted by centrifugation, re-suspended in 50 μl sterile PBS, and injected subcutaneously into rear footpads using a 0.5-cc insulin syringe (28G × 0.5 in). Injected footpads were re-measured after 24 hr. The thickness of each footpad prior to injection was subtracted from the post-injection value to obtain the net swelling. Where indicated, the DCs were pretreated with the following inhibitor drugs: 20 μM NS-398 (COX-2 (PTGS2) inhibitor, Cayman Chemical), 100 μg/ml dexamethasone (glucocorticoid, Sigma-Aldrich), 20 μM VAS2870 (NAPDH oxidase inhibitor, Enzo Life Sciences), 100 μM Suramin (P2 receptor inhibitor, Cayman Chemical), and 30 μM KN-62 (P2X7 inhibitor, Sigma-Aldrich).
+ Open protocol
+ Expand
6

Suramin Compound Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suramin was purchased from Cayman Chemical Co., USA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!